A 54 year old man from New Hampshire received a genetically modified pig kidney transplant on June, 14 at Massachusetts General Hospital. The surgery is part of experimental xenotransplant research aimed to determine whether animal organs might be viable solutions one day, addressing severe shortage of human donor kidneys. Doctors report that the patient is faring well so far, and he stated that he wanted to contribute to the scientific progress. This marks a significant step as clinical xenotransplant trials are about to formally begin. Read More
Other Posts
Bioethics, AI Politics, and a New World Order: Online School Program, December 15-20, 2025 Call for Applications! Join us for an immersive online winter school program exploring the intersection of bioethics, AI politics, and global [...]
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new [...]
Empire of AI by Karen Hao is an investigative account of the rise of OpenAI and the new frontier of artificial intelligence. With vivid reportage from Silicon Valley and the Global South, Hao exposes how [...]
Join the Conversation: Bioethics, AI Politics, and a New World Order Online Winter School | December 15-20, 2025 The world is at a crossroads, facing complex challenges that require a deep understanding of the intersection [...]
New research from Washington University School of Medicine shows Alzheimer’s disease disrupts the brain’s circadian clock, disturbing the day–night rhythm of hundreds of genes vital for brain health. This circadian disturbance results in inflammation and [...]
The article describes how the author’s mother, a kidney-transplant patient in China, increasingly turned to the AI medical chatbot DeepSeek for health advice, finding it more comforting, accessible, and “humane” than busy hospital doctors. However, [...]
